Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Nature Nanotechnology|September 23, 2024
Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapiesEnbo Zhu, Jiaji Yu, Yan-Ruide Li, et al.
Journal of the American Heart Association|December 17, 2019
PLF-1 (Proliferin-1) Modulates Smooth Muscle Cell Proliferation and Development of Experimental Intimal HyperplasiaLina Hu, Zhe Huang, Hideki Ishii, et al.
Science (New York, N.Y.)|November 19, 2016
Ultrafine jagged platinum nanowires enable ultrahigh mass activity for the oxygen reduction reactionMufan Li, Zipeng Zhao, Tao Cheng, et al.
Nature Communications|February 1, 2025
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignanciesYan-Ruide Li, Ying Fang, Siyue Niu, et al.
Journal of the American Heart Association|July 16, 2017
Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic StressEnbo Zhu, Lina Hu, Hongxian Wu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 2, 2016
Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling PathwayHongxian Wu, Xian Wu Cheng, Lina Hu, et al.
Nature|March 9, 2018
Monolayer atomic crystal molecular superlatticesChen Wang, Qiyuan He, Udayabagya Halim, et al.
Cell Reports. Medicine|August 30, 2025
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cellsYan-Ruide Li, Junhui Hu, Zhe Li, et al.
Nature Biomedical Engineering|October 25, 2024
Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Pageof 7